tiprankstipranks
Trending News
More News >
RegenXBio (RGNX)
NASDAQ:RGNX

Compare RegenXBio (RGNX) vs. Competitors

Compare
1,041 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
RegenXBio
$11.16
$564.95M
-3.20
41.27%
9 Buy
0 Hold
0 Sell
Strong Buy
Solid Biosciences
$6.46
$503.30M
-2.59
94.58%
11 Buy
0 Hold
0 Sell
Strong Buy
Monopar Therapeutics Inc
$60.38
$403.49M
-17.56
42.07%
11 Buy
0 Hold
0 Sell
Strong Buy
Monte Rosa Therapeutics
$20.52
$1.56B
67.19
218.14%
8 Buy
0 Hold
0 Sell
Strong Buy
Inhibrx Biosciences Inc
$85.32
$1.11B
-7.45
462.88%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
RGNX
RegenXBio
11.16
3.34
42.71%
SLDB
Solid Biosciences
6.46
3.31
105.08%
MNPR
Monopar Therapeutics Inc
60.38
16.83
38.65%
OPT
GLUE
Monte Rosa Therapeutics
20.52
14.01
215.21%
INBX
Inhibrx Biosciences Inc
76.27
63.55
499.61%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts